Market Overview

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Ambit Biosciences Corporation of Class Action Challenging the Fairness of the Sale of the Company to Daiichi Sankyo Company, Ltd. -- AMBI


NEW YORK, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors of Ambit Biosciences Corporation ("Ambit" or "the Company") (Nasdaq: AMBI) of claims of breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Daiichi Sankyo Company, Ltd. A complaint was filed in Delaware state court.

Click here to learn more about the investigation:

Under the terms of the transaction, Ambit shareholders will receive $15.00 in cash for each share of Ambit stock they own. The claims concern whether the Board of Ambit breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Daiichi Sankyo Company, Ltd. is underpaying for Ambit shares.

If you own Ambit common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (866) 367-6510
View Comments and Join the Discussion!